As of 2024-07-27, the Relative Valuation of Abbvie Inc (ABBV) is 129.07 USD. This relative valuation is based on P/E multiples. With the latest stock price at 185.16 USD, the upside of Abbvie Inc based on Relative Valuation is -30.3%.
The range of the Relative Valuation is 116.07 - 175.39 USD.
| Range | Selected | |
| Trailing P/E multiples | 34.6x - 51.7x | 40.0x |
| Forward P/E multiples | 32.3x - 46.0x | 34.1x |
| Fair Price | 116.07 - 175.39 | 129.07 |
| Upside | -37.3% - -5.3% | -30.3% |
| Date | P/E |
| 2024-07-26 | 54.56 |
| 2024-07-25 | 53.68 |
| 2024-07-24 | 51.92 |
| 2024-07-23 | 51.02 |
| 2024-07-22 | 51.16 |
| 2024-07-19 | 50.78 |
| 2024-07-18 | 50.43 |
| 2024-07-17 | 51.64 |
| 2024-07-16 | 49.86 |
| 2024-07-15 | 49.51 |
| 2024-07-12 | 50.17 |
| 2024-07-11 | 50.06 |
| 2024-07-10 | 49.54 |
| 2024-07-09 | 49.52 |
| 2024-07-08 | 49.07 |
| 2024-07-05 | 49.28 |
| 2024-07-03 | 48.28 |
| 2024-07-02 | 48.90 |
| 2024-07-01 | 50.20 |
| 2024-06-28 | 50.54 |
| 2024-06-27 | 49.79 |
| 2024-06-26 | 50.43 |
| 2024-06-25 | 50.31 |
| 2024-06-24 | 50.90 |
| 2024-06-21 | 50.21 |
| 2024-06-20 | 50.72 |
| 2024-06-18 | 50.49 |
| 2024-06-17 | 50.00 |
| 2024-06-14 | 49.68 |
| 2024-06-13 | 49.08 |
| 2024-06-12 | 48.94 |
| 2024-06-11 | 49.41 |
| 2024-06-10 | 50.23 |
| 2024-06-07 | 49.92 |
| 2024-06-06 | 49.67 |
| 2024-06-05 | 48.75 |
| 2024-06-04 | 47.78 |
| 2024-06-03 | 47.20 |
| 2024-05-31 | 47.51 |
| 2024-05-30 | 46.06 |
| 2024-05-29 | 45.61 |
| 2024-05-28 | 45.77 |
| 2024-05-24 | 46.28 |
| 2024-05-23 | 46.63 |
| 2024-05-22 | 47.03 |
| 2024-05-21 | 48.01 |
| 2024-05-20 | 48.49 |
| 2024-05-17 | 49.04 |
| 2024-05-16 | 48.43 |
| 2024-05-15 | 48.26 |